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It has become increasingly clear that caspases, far from being merely cell death effectors,
have a much wider range of functions within the cell. These functions are as diverse as
signal transduction and cytoskeletal remodeling, and caspases are now known to have an
essential role in cell proliferation, migration, and differentiation. There is also evidence
that apoptotic cells themselves can direct the behavior of nearby cells through the
caspase-dependent secretion of paracrine signaling factors. In some processes, including
the differentiation of skeletal muscle myoblasts, both caspase activation in differentiating
cells as well as signaling from apoptotic cells has been reported. Here, we review the
non-apoptotic outcomes of caspase activity in a range of different model systems and
attempt to integrate this knowledge.
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INTRODUCTION
Caspases are intracellular cysteine proteases that cut after specific
aspartic acid residues. Inmammals, 18 caspases have been charac-
terized (Table 1), the majority of them playing roles in mediating
apoptotic cell-demolition (Cohen, 1997). During apoptosis, these
“killer caspases” cleave numerous cellular proteins, and they are
the primary effectors responsible for taking apart the cell dur-
ing apoptosis, playing a major proteolytic role in the disassembly
of the nucleus and the cytoskeletal structure (Lüthi and Martin,
2007).
Caspases are present in all cells as inactive zymogens, called
procaspases. They are activated through cleavage to generate the
subunits that form an active caspase (Pop and Salvesen, 2009).
At the apex of the activation cascade are the so-called initia-
tor caspases (Table 1). Upon exposure to an apoptotic stimulus
they become recruited to specific adaptor proteins which then
assemble into activation platforms, which are large multimeric
protein complexes mediating activation of the initiator caspases
(reviewed in Mace and Riedl, 2010). Initiators activate down-
stream effectors which rapidly disassemble the cell. The ability of
these caspases to kill cells is controlled, in part, by the inhibitor of
apoptosis proteins (IAPs) which bind to active caspases and either
inhibit proteolytic activity or induce ubiquitin-mediated caspase
degradation (Mace et al., 2010).
Different activation platforms classify the main apoptotic
pathways. The extrinsic pathway is initiated at the cell mem-
brane by ligands of receptors of the tumor necrosis factor (TNF)
receptor family. Ligand-binding leads to assembly of the death-
inducing signaling complex (DISC) containing these receptors.
Caspase-8 and -10 are recruited to the DISC and then acti-
vated, in a process that requires the adaptor protein FADD.
The intrinsic pathway is initiated by mitochondria, whose outer
membranes become permeable to cytochrome c upon certain cel-
lular stresses. Released cytochrome c then binds to the adaptor
protein APAF-1 which subsequently assembles into a large hep-
tameric protein complex, the so-called apoptosome, which is the
activation platform for caspase-9. The release of cytochrome c
is controlled by proteins of the Bcl-2 family (Tait and Green,
2010). Concomitant with release of cytochrome c, other small
proteins may be released, some of which block IAPs allowing for
unrestrained caspase activation.
The majority of studies of caspases have focused on their
roles as cell killers. There were some notable exceptions describ-
ing caspase-dependent cellular differentiation processes that
involve denucleation or other degenerative events (Fernando and
Megeney, 2007), but these appear to represent a limited or frus-
trated apoptosis, rather than a fundamentally different process.
More recently, the study of apoptotic caspases has broadened
to include caspase-dependent paracrine signaling from apop-
totic cells to explain how apoptotic cells alter the behavior of
surrounding cells (Li et al., 2010a).
However, it has also emerged that apoptosis-associated cas-
pases play non-apoptotic roles and that they are not simply
destructive. Examples of these are cell differentiation (Fernando
and Kelly, 2002), embryonic development (Miura, 2012; Suzanne
and Steller, 2013), motility (Barbero et al., 2009), and compen-
satory proliferation (Fan and Bergmann, 2008). Within these
processes, the “killer” caspases clearly do not cause cell demoli-
tion. This gives caspases an entirely new role in determining the
fate or behavior of cells. Thus, caspases drive in a far wider range
of cellular behaviors than previously known.
There are several theories to explain how apoptotic caspases
can lead to non-apoptotic outcomes (Figure 1). In one mecha-
nism, the “cell-autonomous” or “direct” model, caspase activity
leads to altered cell behavior through the modulation of regula-
tory networks, such as through cleavage of cell cycle repressors to
alter cell proliferation (Schwerk and Schulze-Osthoff, 2003; Woo
et al., 2003), activation of gene transcription to induce skeletal
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Table 1 | Roles of caspases.
Caspase Conventional role Other roles
Caspase-1 Inflammatory response (Kuranaga and Miura, 2007) Unknown
Caspase-2 Apoptosis (Initiator) (Inoue et al., 2009) DNA damage response (Fava et al., 2012)
Caspase-3 Apoptosis (Executioner) (Kuranaga and Miura, 2007) Differentiation of many cell types (see Table 2)
Caspase-5 Inflammatory response (Fuchs and Steller, 2011) Possibly tumor suppression (Soung et al., 2008)
Caspase-6 Apoptosis (Initiator) (Inoue et al., 2009) Unknown
Caspase-7 Apoptosis (Executioner) (Inoue et al., 2009) Unknown
Caspase-8 Apoptosis (Executioner) (Fuchs and Steller, 2011) Embryonic development (Suzanne and Steller, 2013), motility (Helfer
et al., 2006), tumor metastasis (Barbero et al., 2009), T-cell proliferation
(Kennedy et al., 1999), cell cycle regulation (Zhang et al., 2001;
Hashimoto et al., 2011), bacterial infection response (Kayagaki et al.,
2011)
Caspase-9 Apoptosis (Initiator) (Cohen, 1997) Differentiation of many cell types (see Table 2)
Caspase-10 Apoptosis (Initiator) (Inoue et al., 2009) Immune response to dsRNA (Takahashi et al., 2006), possible tumor
suppressor (Park et al., 2002)
Caspase-11 Inflammatory response (Li et al., 2007) Cell migration (Li et al., 2007)
Caspase-12 Inflammatory response (Leulier et al., 2000) Unknown
Caspase-14 Keratinocyte differentiation (Zermati et al., 2001) Unknown
Caspase-15 Apoptosis (Initiator) (Eckhart et al., 2005) Unknown
Caspase-16 Unknown, phylogenetic association with caspase-14
(Eckhart et al., 2008)
Unknown
Caspase-17 Unknown, phylogenetic association with caspase-3 (Eckhart
et al., 2008)
Unknown
Caspase-18 Unknown, phylogenetic association with caspase-8 (Eckhart
et al., 2008)
Unknown
The majority of caspases are primarily involved in programmed cell death, and the minority are primarily involved in the generation of immune responses. Most have
been discovered to play other roles as well.
FIGURE 1 | Cell-autonomous vs. non-cell-autonomous models of
caspase signaling. (A) Cell-autonomous model. In the proliferating cell, a
non-apoptotic caspase signaling pathway leads to a change in cell behavior
through modulation of gene expression, cytoskeletal restructuring, or other
means. This signaling is endogenous to the proliferating cell itself, and no
apoptotic cell signaling is involved. (B) Non-cell-autonomous model. In this
model, caspase activity within apoptotic cells lead to the generation of
signaling factors which stimulate the cell behavior change of nearby cells in
a paracrine fashion.
muscle differentiation (Larsen and Megeney, 2010) or cleavage
of cytoskeletal proteins to influence cell motility (Helfer et al.,
2006). In these cases the caspase activity is “autonomous” in that
the entire process of caspase activation, cleavage of substrates, and
downstream effects on cell behavior all occur within the same cell.
In this cell autonomous model, it is as yet unclear how apop-
totic caspase activity is harnessed for non-apoptotic purposes
without killing the cell, although work inDrosophila melanogaster
has begun to unravel this problem. For example, a recent report of
caspase activation in Drosophila proposes a model in which both
the magnitude and rate of caspase activation is controlled, which
can give rise to high (apoptotic) levels of caspase activity as well
as low (non-apoptotic) levels of activity (Florentin and Arama,
2012). It is also possible that, unlike the traditional model where
executioner caspases are only activated upon receipt of a cell stress
signal, there is a constant basal level of activated caspases within
the cell, but these are normally held in check by inhibitory mech-
anisms. Such basal levels of caspase activity have been found in
the context of cell behavior changes in glioblastoma cells, where
low levels of constitutively-active caspase-8 and -3 are found to
be necessary for cell migration and invasion (Gdynia et al., 2007).
Along with this, relatively high levels of caspases activity may be
tolerated if they can be sequestered within their target organelle
or sub-cellular region, as is observed in the dendritic pruning of
neurons (Williams et al., 2006), in spermatid individualization in
Drosophila (Arama et al., 2007; Kaplan et al., 2010), and in the
nuclear degradation of keratinocytes (Weil et al., 1999).
In the “non-autonomous” or “indirect” model to explain the
role of caspases in non-apoptotic processes, the caspase activity is
localized within apoptotic cells, catalyzing the generation of secre-
tory paracrine signaling factors or enabling cell surface-mediated
signaling (Hochreiter-Hufford et al., 2013). This model is indirect
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in that the caspase activity is associated with one cell, while
the downstream effect is induced in another cell by an inter-
cellular signaling event. In this model the caspase-mediated non-
apoptotic effects do not necessarily require the survival of the
“caspase-active” cell, as apoptotic cells are still quite capable of
signaling to their environment (Jäger and Fearnhead, 2012).
Here, we review the major non-apoptotic roles of caspases dis-
covered to date, and discuss these findings in light of the direct
and indirect theories of caspase signaling, with a particular focus
on skeletal muscle. This is a rapidly advancing field of study, and
a summation of the current state of the field is necessary.
TISSUE REPAIR AND REGENERATION
Caspases are key players in the homeostatic balance between
apoptosis and regeneration used to maintain tissue structure and
function. In response to injury, dead cells engage in a signaling
behavior which drives the proliferation of cells at the periphery of
the site of injury until damaged portion of tissue is replaced with
a new section of the same size and shape (Figure 2) (Bergmann
and Steller, 2010). The role of caspases in repair and regeneration
has been demonstrated in several different experimental models.
In the simple metazoan Hydra, surgical-induced injury
produces an apoptotic response which stimulates a compen-
satory proliferative mechanism in surrounding progenitor cells.
Treatment with pan-caspase inhibitors abolishes this regenerative
response (Cikala et al., 1999; Chera et al., 2009). Regeneration in
the amphibian Xenopus requires caspase-mediated events (Tseng
et al., 2007), as does tissue regeneration in planaria (Fuchs and
Steller, 2011), and the regeneration of newt forelimbs (Vlaskalin
et al., 2004).
Regeneration of mammalian tissue is never so dramatic but
some tissues, like the liver, can undergo remarkable regeneration
after injury (Taub, 2004). Liver regeneration and the healing of
skin wounds is impaired in caspase-3 and -7 deficient mice, show-
ing that the role of caspases in regenerative processes is conserved
in mammals (Li et al., 2010a).
FIGURE 2 | Model of compensatory proliferation. Caspase activity within
apoptotic cells leads to the activation of the prostaglandin E2-synthesis
pathway. Secreted prostaglandin E2 binds to E2 receptors on
proliferation-competent cells, leading to changes in gene expression which
trigger proliferation. Abbreviations: iPLA2, Phospholipase A2; COX-2,
Cyclooxygenase-2; PGEs, Prostaglandin E synthase; PGE2,
Prostaglandin E2.
Paracrine molecules secreted by the apoptotic cells appear to
be important in caspase-dependent regeneration. Prostaglandin
E2 is one such a molecule, as its production pathway is directly
controlled by caspase-3 (Boland et al., 2013), and has a wide num-
ber of roles in regeneration and proliferation (Castellone et al.,
2005; Goessling et al., 2009; Morata et al., 2011; Beaulieu et al.,
2012; Boland et al., 2013). This effect is exerted through transient
activation of the Wnt-β-catenin pathway via binding to members
of the EP receptor family (Goessling et al., 2009).
Lysophosphatidylcholine (LPC) is another molecule which
mediates caspase-activity-induced regenerative responses. It is
produced by apoptotic cells, and its presence in the intersti-
tial medium acts as an attraction signal to phagocytes (Lauber
et al., 2003). Moreover, LPC induces the differentiation of ker-
atinocytes, which is a necessary step in the wound healing
response in skin (Ryborg et al., 2004).
Sphingosine-1-phosphate is another molecule that is secreted
by apoptotic cells and is a chemoattractant signal for immune
cells (Brecht et al., 2011). It is produced by the enzyme cerami-
dase, and is a signal that drives growth arrest and differentiation,
as well as cell migration and adhesion (Mao and Obeid, 2008), all
of which are involved in wound-healing responses.
Fractalkine (CX3CL1) is a large peptide that engages in pro-
survival functions in many cell types (White and Greaves, 2012)
and is released from apoptotic cells in a caspase-dependant pro-
cess (Truman et al., 2008). Fractalkine is normally associated
with immune cell chemotaxis (Chazaud et al., 2003), but it is
also known that soluble fractalkine promotes both migration of
endothelial cells and differentiation of osteoblasts (Koizumi et al.,
2009). This makes it another potential paracrine signaling factor
released by apoptotic cells to modulate tissue regeneration.
From the examples described, it is seen that caspase activity
in a dying cell can indirectly induce compensatory prolifera-
tion of neighboring cells as part of the regenerative response
to injury. Thus, regenerative processes conform to the indirect,
apoptotic cell-driven model of caspase function in non-apoptotic
processes. However, caspases can also regulate cell proliferation
in a cell-autonomous manner through the cleavage of cell cycle
regulators.
LYMPHOCYTE PROLIFERATION
There are hundreds of confirmed caspase substrates (Lüthi and
Martin, 2007; Johnson and Kornbluth, 2008), although the func-
tional significance of cleavage is often uncertain. Among this
large group there are several key cell cycle regulators (Hashimoto
et al., 2011) and a series of studies have implicated both initiator
and effector caspases in the control of the cell cycle of lympho-
cytes. Because of this, abnormal caspase activity can lead to either
depressed or hyperactive cell proliferation.
Through the DISC adaptor protein FADD, caspases-8 and -10
play a role in cell proliferation (Imtiyaz et al., 2009). Peripheral
T-cells from FADD deficient mice show a profound impairment
of proliferation once they are activated by mitogens or antigens,
leading to a reduced number of mature T-cells (Zhang et al.,
1998). This inhibition of proliferation results from a failure to
enter the cell cycle at the beginning of S-phase due to abnor-
mal expression of cyclin-dependent kinases (Zhang et al., 2001).
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Pharmacological inhibition of caspases prevents T-cell prolifera-
tion in vitro supporting the idea that caspase activity is required
for proliferation (Kennedy et al., 1999). The cell cycle role for cas-
pases may not be limited to T-cells as impaired T-cell, B-cell, and
NK-cell proliferation is seen in immune-deficient humans with
caspase-8 defects (Chun et al., 2002).
As well as caspases-8 and -10, caspase-3 has also been found to
play a role in regulating cell proliferation. Proliferative brain cells
were found to contain active caspase-3, localized in the nucleus
(Oomman et al., 2005). In lymphoid cells, caspase-3 supports the
proliferation through cleavage of the CDK inhibitor p27 (Frost
et al., 2001). In these examples, caspase-mediated stimulation of
proliferation appears to be a cell-autonomous event. On the other
hand, proliferating cells utilize caspases in a non-apoptotic capac-
ity to downregulate cell cycle inhibitors which normally keep the
cell in a quiescent state (Zhang et al., 2001; Woo et al., 2003;
Lamkanfi et al., 2007). For example, caspase-3 can exert a strongly
anti-proliferative effect in B-cells through cleavage of p21 and
caspase-3 knockout mice show a hyperproliferative phenotype in
their B-cells (Woo et al., 2003). Thus, killer caspases seem to be
able to exert both positive and negative regulation of cell prolif-
eration through selective cleavage of cell cycle regulators without
necessarily inducing apoptosis.
Caspase-1, which is involved in toxin-sensing (Li et al., 1995;
Franchi et al., 2009), and caspase-11, involved in the production
of inflammatory factors (Kayagaki et al., 2011) have long been
associated with inflammation and immunity and are not cen-
tral to cell death processes. However, it has more recently been
discovered that apoptotic caspases also have roles in immunity.
This can be through their role in the differentiation programs of
immune cells, such as with caspase-8 paralog Dredd (Leulier et al.,
2000), or through the modulation of the immune response itself,
such as with caspase-12 (Saleh et al., 2004) and caspase-3 paralog
ced-3 (Aballay and Ausubel, 2001). Such modulation may occur
through the generation of inflammatory and anti-inflammatory
factors (Kuranaga and Miura, 2007) or through their role in the
apoptosis of infected cells.
DIFFERENTIATION
Caspases engage in irreversible signal transduction (Kuranaga,
2012). Such irreversible signaling mechanisms are suitable for
guiding cell fate choices, such as differentiation. Indeed, such
caspase signaling has been found to play important roles in the
terminal differentiation programs of several cell types, both in
early development, and in tissue regeneration.
The first cell types in which caspases were found to have a
direct role in differentiation had one feature in common: their
differentiation programs bore a strong resemblance to apop-
tosis. For example, during terminal differentiation of the lens
fiber cells degenerative processes including organelle degrada-
tion, chromatin condensation, and DNA fragmentation all occur,
and are mediated by the activity of caspases (Ishizaki et al.,
1998). The time required for this apoptosis-like process is much
longer than that required for caspase-driven cell death, sug-
gesting a more controlled and meticulous version of the same
general procedure. Soon after this, erythrocytes and keratinocytes
were also found to utilize caspase activity in their terminal
differentiation programs (Eckhart et al., 2000; Zermati et al.,
2001).
Subsequently, it was found that caspases also play roles in
differentiation programs that bore no major similarity to apopto-
sis. An example of this is the differentiation of peripheral blood
monocytes into macrophages, which requires the activation of
the caspases-3, -8, and -9 for differentiation (Sordet et al., 2002).
Deletion of caspase-3 limits the cytokine-induced differentiation
of hematopoietic stem cells (Janzen et al., 2008) and the differ-
entiation ability of iPSCs is enhanced by transient induction of
caspase activity (Li et al., 2010b). Several other caspase-dependent
cell differentiation programs have been discovered, including
those of skeletal myoblasts, osteoblasts, spermatids, placental
trophoblast, and embryonic and neural stem cells (Table 2).
A well-studied example of caspase-stimulated in vitro differ-
entiation is that of mouse muscle myoblasts into multinucleated
myotubes (Fernando and Kelly, 2002; Murray et al., 2008; Larsen
et al., 2010). In this model capase-3-mediates activation in dif-
ferentiating mouse myoblasts of a specific DNase called CAD
(Larsen et al., 2010). Normally CAD (DFF40 in humans) is bound
to a chaperone called ICAD (DFF45) that inhibits the nuclease
activity of CAD. Caspase-3 mediated cleavage of ICAD releases
CAD, allowing it to cleave DNA. This is a key step in the gen-
eration of oligonucleosomal DNA fragments seen in apoptosis.
Perhaps surprisingly, activation of CAD occurs in differentiating
myoblasts and RNAi directed against CAD causes profound inhi-
bition ofmyoblast differentiation. Larsen et al. propose that CAD-
dependent activation of p21 expression is the key event explaining
this defect as p21 expression is an early and necessary event in
myoblast differentiation (Larsen et al., 2010). In other words,
it is proposed that caspase-3 drives non-apoptotic outcomes by
inducing expression of specific genes. In addition, Fernando et al.
showed that microinjection of active caspase-3 induced expres-
sion of muscle specific genes (Fernando and Kelly, 2002). These
two reports support the idea that caspase activity is present
in the differentiating myoblast (the direct/autonomous model).
Caspase-3 activation during differentiation requires caspase-9
and is blocked by overexpression of Bcl-XL (Murray et al., 2008),
which implicates the intrinsic or mitochondrial apoptotic path-
way, although the role of cytochrome c release or Apaf-1 in this
differentiation has not been conclusively demonstrated.
Although this seems like strong evidence for cell-autonomous
model of caspase action, there are also data to support non-
autonoumous roles for caspase activity in muscle differentiation.
It has been found that myoblast fusion is driven by apoptotic
cells through a phosphatidylserine-mediated activation of the
BAI1 receptor. During apoptosis, caspase-dependent presenta-
tion of phosphatidylserine (PS) on the surface of dying cells
is an important “eat me” signal for phagocytes and so plays a
central role in the clearance of apoptotic bodies. Adding apop-
totic cells to cultures where caspase activity has been abolished
with pharmacological inhibitors restores myoblast fusion, and
adding annexin V, a PS-binding protein, blocks myoblast fusion
(Hochreiter-Hufford et al., 2013). This finding thus supports
the non-cell-autonomous model, in that fusion is driven by
caspase-mediated presentation of cell-surface signaling factors
on apoptotic cells. It may be that both cell autonomous and
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Table 2 | Caspase involvement in the differentiation programs of several cell types.
Differentiation morphology Cell type Caspase(s) References
Apoptosis-like Erythrocyte Caspase-2, -3, -9 Zermati et al., 2001
Keratinocyte Caspase-3, -14 Weil et al., 1999; Eckhart et al., 2000
Epithelial lens Caspase-3 Ishizaki et al., 1998
Megakaryocyte Caspase-3, -9 De Botton et al., 2002
Non-apoptosis-like Macrophage Caspase-3, -8, -9 Sordet et al., 2002; Kang and Ben-Moshe, 2004
Skeletal myoblast Caspase-3, -9 Fernando and Kelly, 2002; Murray et al., 2008;
Larsen et al., 2010
Neuron Caspase-3, -1 Fernando et al., 2005; Vaisid et al., 2005
Glial cell Caspase-3 Oomman et al., 2006
Osteoblast Caspase-2, -3, -8 Mogi and Togari, 2003
Placental trophoblast Caspase-8 Black et al., 2004
Embryonic stem cell Caspase-3 Fujita et al., 2008
Hematopoietic stem cell Caspase-3 Janzen et al., 2008
Spermatid Drice (Caspase-3), Dredd
(Caspase-8), Dronc (Caspase-9)
Arama et al., 2003, 2007; Huh et al., 2004; Kaplan
et al., 2010
Odontoblast Caspase-7 Matalova et al., 2013
Some programs follow a “frustrated apoptosis” phenotype, while others have a distinctly non-apoptotic-like morphology.
non-autonomous roles for caspases are important in myoblast
differentiation.
A question that arises with the cell-autonomous model of
caspase activity; how is this activity prevented from progress-
ing to apoptosis? The convention is that activation of apoptotic
caspases is an irreversible threshold event, leading to a run-
away process of proteolytic cleavage, culminating in apoptotic
cell death. If caspases truly are activated within differentiating
cells themselves, there must be some mechanism for restraining,
sequestering, or otherwise preventing this activity from killing the
cell. Members of the IAP family are important caspase regula-
tors (Mace et al., 2010), but there is so far little evidence that
any of these proteins regulates caspase activity during muscle
differentiation. Kaplan et al. showed that in spermatids there is
a gradient of the giant IAP protein, dBRUCE, that establishes
a gradient of caspase activity during the process of spermatid
individualization in Drosophila (Kaplan et al., 2010). There is
also other evidence for caspase localization being important dur-
ing differentiation (Table 3). Interestingly, myogenin expressing
satellite cells from young donors display active caspase-3 only at
the nucleus, whereas myogenin expressing satellite cells from aged
donors contain active caspase-3 both at the nucleus and at the
cytoplasm. The satellite cells from aged donors also show a higher
level of apoptotic cell death and together these data suggest a
model in which the failure to properly localize active caspase-3
leads to satellite cell death and impaired muscle regeneration as
we age (Fulle et al., 2013).
Moving to in vivomodels of muscle differentiation, the role of
caspases in regeneration becomes less clear. In caspase-9 (Hakem
et al., 1998; Kuida et al., 1998) and caspase-3 (Kuida et al.,
1996) knock-out mice embryonic myogenesis appears normal
so the role of caspase-9 and caspase-3 in muscle differentia-
tion in vivo at first appears unlikely. However, besides prenatal
myogenesis, there is a distinct postnatal muscle development
Table 3 | Compartmentalization of caspases has been found to be
used in the differentiation programs of several cell types.
Cell type Caspase Form of compartmentalization
Platelet Caspase-3 During platelet formation, caspase
activity is localized in punctate bodies
within the cytoplasm (De Botton
et al., 2002)
Lens cell Caspase-3 Partial localization to equatorial
epithelium (Weber and Menko, 2005)
Spermatid Drice (Caspase-3) Localized within the cystic bulge of
the cytoplasm (Kaplan et al., 2010)
Keratinocyte Caspase-3 Probable localization in the nucleus
during enucleation (Okuyama et al.,
2004)
Glia Caspase-3 Active caspase localized to the
nucleus (Oomman et al., 2005, 2006)
process as well as repair and regeneration processes in adult
muscle that have not been evaluated in the caspase knock-out
mice. Defects in these processes underlie a range of muscu-
lar dystrophies and age-related sarcopenia. In some instances,
defects that have profound effects on muscle regeneration do not
affect embryonic muscle development. For example, mice lack-
ing caveolin-3 or expressing a Pro104Leu mutation in caveolin-3
(a model for human Limb Girdle Muscular Dystrophy 1C) show
normal muscle development but muscle degeneration after 8
weeks of age (Hagiwara et al., 2000; Sunada et al., 2001). It is
therefore possible that caspase-driven processes are important
primarily in regeneration of adult muscle rather than muscle
development but defects have not been observed in caspase defi-
cient mice because of the perinatal lethality associated with these
knock outs.
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Activation of caspase-8 by TNF induces apoptosis and blocks
muscle regeneration in in vivo models of cachexia (Moresi et al.,
2008, 2009), data that also appears inconsistent with a model in
which caspase activity is required for differentiation. The con-
flicting reports of the role of caspases in muscle differentiation
may be reconciled by a model in which caspase-8 induces high
levels of effector caspase activity that kill cells while differentia-
tion is associated with lower effector caspase activity. Just such
a switch between death and differentiation has been reported in
Drosophila models (Florentin and Arama, 2012). Alternatively,
TNF-dependent caspase activation may result in a different local-
ization of active caspases compared to caspase activation associ-
ated with differentiation as discussed above for young and aged
satellite cells (Fulle et al., 2013).
It is also possible that a particular cellular differentiation pro-
cess involves more than one caspase-driven step. Muscle differen-
tiation may represent an example of this, with caspase signaling
from apoptotic cells as well as caspase activity in the differentiat-
ing cells. Differentiating myoblasts may even rely on their caspase
activity to drive more than one process during differentiation.
Larsen et al. present compelling evidence that caspase-3 mediated
DNA damage drives changes in gene expression that are required
for myoblast differentiation (Larsen et al., 2010). Others have
argued that primary consequence of preventing caspase activation
in differentiation is a failure of myoblast fusion (Murray et al.,
2008). It is possible that caspases contribute to myoblast fusion by
influencing cell motility, as this is required for both muscle devel-
opment (Brand-Saberi et al., 1996; Molkentin and Olson, 1996)
and regeneration (Seale and Rudnicki, 2000).
MOTILITY AND METASTASIS
Cellular locomotion essentially involves the continuous deforma-
tion and manipulation of the cytoskeleton to achieve movement.
Caspases are the major manipulators of cytoskeletal structure
during apoptosis, so it is conceivable that caspases could also have
a role in enabling cell motility. In support of this model, in vitro
studies have shown that caspase-8-knockout mouse embryonic
fibroblasts are both motility-defective, and unable to form proper
lamellipodia (Helfer et al., 2006). It is thought that caspase-8
engages in a multiprotein complex with calpain to cleave focal
adhesion substrates (Helfer et al., 2006).
Additionally, the embryonic lethality of caspase-8 homozygous
knockout mice has been attributed to the failure to develop a
functional circulatory system through a defect in endothelial cell
migration (Kang and Ben-Moshe, 2004). It is as yet unknown
how caspase-8 mediates migration. It could be mediated through
activation of downstream effector caspases like caspase-3, lead-
ing to modification of the cytoskeleton, or it could act through
a separate pathway that does not involve executioner caspases.
There is even evidence suggesting that the catalytic activity of
caspase-8 is not required for its effects on cell motility (Senft
et al., 2007). In addition to caspase-8, caspase-3 has also been
implicated in cell motility. Pharmacological inhibition of caspase-
3 activity reduces cancer cell motility and invasiveness (Gdynia
et al., 2007).
Metastasis of tumor cells involves cellular migration and inva-
sion of tissues, and the subsequent growth of secondary tumors
at distant sites. Normally, cells are unable to escape into systemic
circulation, as detachment from their basement matrix induces
cell death through anoikis or amorphosis (Mehlen and Puisieux,
2006). However, when apoptosis is compromised through silenc-
ing of the downstream effector caspase-3, caspase-8 can act to
promote metastasis. In this state, caspase-8 enters into a complex
with FAK and CPN2, engaging a signaling pathway which induces
cell migration (Barbero et al., 2009).
In a Drosophila model of tumor invasion, a non-apoptotic
effector caspase pathway is utilized to activate the key inva-
sion protein Mmp1 via JNK signaling (Rudrapatna et al., 2013)
(Figure 3). It has been proposed that this cell invasion is
achieved through co-opting functions of apoptotic caspase such
as cytoskeletal modification. This could be extrapolated as a
general feature of non-apoptotic caspase activities in different
processes. Together, this suggests a new way of thinking about
caspases. Perhaps it is more constructive to think of caspases as
cell-structure modifying enzymes rather than as just cell death
effectors. This idea is consistent with emerging data showing the
role of caspases in neuronal plasticity.
NEURAL SIGNALING AND POTENTIATION
During early development, live imaging of caspase activity in
the brain shows a complex pattern of expression and subcel-
lular localization, occurring in discrete waves (Oomman et al.,
2006). These waves of activity correspond to specific periods of
brain maturation. Here, we look at the roles of this non-apoptotic
caspase activity in neuronal network pruning, synaptic plastic-
ity, signal modulation, and axonal guidance (Hyman and Yuan,
2012).
FIGURE 3 | Model of caspase-mediated tissue invasion based on
Drosophila studies. A sub-apoptotic level of caspase activation leads to
the activation, via JNK signaling, of matrix metalloproteases. This
metalloprotease activity is a necessary step in the invasion of tissues.
Abbreviations: JNK, Jun kinase; Mmp1, Matrix metalloprotease 1; Hid,
head involution defective; Dronc, Drosophila Nedd2-like caspase; Drice,
Drosophila ICE.
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Pruning of axons and dendrites are the mechanisms through
which undesired neural connections are removed. Neural net-
work pruning during larval development in Drosophila is carried
out through severing the connection between the outgrowth and
the cell body, by means of localized executioner caspase activ-
ity, which is mediated by the spatially-restricted degradation of
IAP proteins through caspase-3-like activity. An essential step in
the process is degradation of DIAP1, a key inhibitor of caspase
activity. Inhibition of the caspase-3-ortholog Dronc prevents this
pruning process (Kuo et al., 2006) (Figure 4).
In mammals, caspases were found to modulate synaptic plas-
ticity through localized activation within synaptic terminals and
neurites in response to stressors. Caspase-3 activity leads to
dephosphorylation and internalization of AMPA-type receptors.
The loss of these receptors causes degradation of the local den-
dritic spine. This leads to overall modulation of glutamate signal-
ing. Consequentially, caspases have a role in long-term depression
(LTD) of neurons, and overexpression of the anti-apoptotic pro-
teins XIAP or Bcl-xL prevent this LTD (Li et al., 2010c).
Axonal guidance is carried out through the diffusion of molec-
ular signals by the target site, generating a chemotrophic gradient
for the axon. Caspases also contribute to this chemotrophic
migration by regulating the growth of neurites, through local-
ized proteolytic activity within growth cone structures. Caspase-3
FIGURE 4 | Caspases in neuronal restructuring and signaling. Synaptic
plasticity : Through cleavage of Akt, caspase-3 is involved in the endocytosis
of AMPA receptors, leading to Long-Term Depression (LTD) of synaptic
signaling. Axonal pruning: Localized proteosomal degradation of Inhibitor of
Apoptosis proteins (IAPs) within axons lead to a localized caspase activity
which shears the axon from the cell body. This process does not kill the
parent neuron. Growth cone mobility: Netrin-1 acts as a chemoattractant,
signaling MAP Kinase-mediated activation of caspase-3, which remodels
the cytoskeletal structure within the growth cone, allowing axonal migration
down the chemotrophic gradient. Abbreviations: AMPAR, AMPA receptor;
Ubc1, Ubiquitin-conjugating enzyme E2 1; DIAP1, Drosophila Inhibitor of
Apoptosis 1; MAPK, Mitogen-activated protein kinase.
activation is required for this response, as LPA-induced growth
cone collapse and netrin-1-induced growth cone attraction are
both blocked by caspase-3 inhibitors (Campbell and Holt, 2003).
This caspase-3-mediated effect does not require caspase-9 acti-
vation, suggesting a distinct, non-canonical activation pathway.
It has been speculated that caspase-3 mediated modulation of
growth cones is carried out through degradation of cytoskele-
tal structural elements such as actin and gelsolin (Campbell and
Holt, 2003) and rock-1 (Riento and Ridley, 2003).
Such caspase-mediated modulation of synaptic plasticity, axon
pruning, and growth conemobility appear to be cell-autonomous
events, in that all utilize localized caspase activity within the target
cell, likely through spatially-restricted degradation of inhibitors of
caspase activity.
CONCLUSION
Here, we reviewed the major non-apoptotic roles of caspases
discovered to date. We discussed such roles in terms of differ-
ent cell behaviors such as differentiation, migration, and cell
signaling, and presented evidence for the cell autonomous and
non-cell-autonomous models of caspase signaling.
In some systems, it seems rather clear that a cell autonomous
event is occurring. This is the case in, for example, axonal prun-
ing, where a defined cell autonomous pathway of caspase activa-
tion has been elucidated. Other systems appear to be examples of
the non-cell-autonomous model. An example of this is the pro-
cess of compensatory proliferation, whereby caspase-generated
signals from apoptotic cells stimulate the proliferation of nearby
cells in an intercellular, receptor mediated fashion. Finally, there
are systems where the evidence is conflicting. This includes the
process of myoblast differentiation, in which there appears to be
an essential role for both cell membrane contact with apoptotic,
PS exposing cells, and for the cell autonomous caspase activation
of nucleases to enable the transcription of myogenic genes. Some
further approaches that may prove fruitful for this field include
the live imaging of caspase activity in individual cells undergoing
differentiation, the identification of soluble mitogenic signaling
factors from apoptotic cells, and investigation of the interplay
between caspase signaling pathways and other signaling pathways.
Regardless of how caspases are regulated in these models, it
seems clear that caspases do indeed have roles other than as effec-
tors of cell death. This new understanding suggests unexpected
complications in situations where caspase-dependent cell death is
considered desitable, such as in response to cancer chemotherapy.
The newfound alternative roles of caspases present the possibility
that chemotherapy drugs may induce a wide range of cell behav-
iors such as increased migration and compensatory proliferation
of cancer cells (Jäger and Zwacka, 2010) that are both unexpected
and unwanted.
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